Danish Drugmakers Offset Weaker Economy to Keep GDP Growing
Denmark’s economy expanded for the third consecutive quarter as Novo Nordisk A/S and other Danish drugmakers enjoy massive
2023-08-15 18:29
European Stocks Lifted by Luxury as China Eases Travel Curbs
European stocks extended gains into a second session, as China’s decision to relax travel curbs offered a lift
2023-08-10 15:58
Novo’s Blockbuster Obesity Drug Still Hit by US Bottlenecks
Novo Nordisk A/S said the supply of its blockbuster obesity medicine Wegovy will continue to be restricted in
2023-08-10 14:52
Novo’s Value Surpasses Denmark GDP After Obesity Drug Boost
Novo Nordisk A/S has just reached another milestone in its meteoric rise: the market value of the Danish
2023-08-09 19:51
PE firm KKR acquires $373 million portfolio of Synovus Bank's prime auto loans
Private equity giant KKR said on Tuesday it had acquired a $373 million portfolio of prime auto loans
2023-08-09 05:57
Weight-Loss Stocks Soar After Obesity-Drug Study Spurs Investor Frenzy
Wall Street’s enthusiasm for all things weight-loss related got a fresh boost Tuesday after results for a Novo
2023-08-09 01:56
Obesity Drug Wegovy Cuts Risk of Heart Attacks and Strokes by 20%, Study Shows
Novo Nordisk A/S shares surged to a record after the Danish company’s blockbuster obesity medicine Wegovy reduced the
2023-08-08 18:48
Bain, Cinven Weighs Sale of €10 Billion Drugmaker Stada
The private equity owners of Stada Arzneimittel AG are weighing options for the German drugmaker, including a possible
2023-08-03 00:27
Novartis raises outlook, maps out Sandoz spin-off
By Ludwig Burger FRANKFURT (Reuters) -Novartis on Tuesday raised its full-year earnings guidance on strong drug sales and mapped out
2023-07-18 13:54
Novartis Raises Outlook, Plans Buyback of Up to $15 Billion
Novartis AG raised its profit outlook and announced plans to buy back as much as $15 billion in
2023-07-18 13:48
Lilly to Pay Up to $2 Billion for Obesity Startup Versanis
Eli Lilly & Co. will acquire closely held Versanis Bio, a startup developing a drug for obesity and
2023-07-14 23:18
Strong U.S. demand eases pressure on Novo to show weight-loss drug's health benefits
By Maggie Fick LONDON Soaring U.S. demand for Novo Nordisk's weight-loss drug has reduced the pressure from investors
2023-07-14 13:15